Financial Results
Cairo Pharmaceuticals (CPCI.CA) Reports Its Financial Results for The Period From 01/07/2025 to 31/03/2026
Published at 17 May 2026 at 10:43Cairo PharmaceuticalsRelated stock:Cairo Pharmaceuticals stockAll Cairo Pharmaceuticals disclosures
Disclosure summary
Company Name: Cairo Pharmaceuticals
ISIN Code: EGS38391C016
Currency: Egyptian Pound
F/S Period: From 01/07/2025 to 31/03/2026
Net profit: 412,811,945
F/S Period: From 01/07/2024 to 31/03/2025
Net Comparative profit: 352,038,575
Audit Status: Reviewed
Source: Cairo Pharmaceuticals
The Audit Committee Report (5,153 KB)
ISIN Code: EGS38391C016
Currency: Egyptian Pound
F/S Period: From 01/07/2025 to 31/03/2026
Net profit: 412,811,945
F/S Period: From 01/07/2024 to 31/03/2025
Net Comparative profit: 352,038,575
Audit Status: Reviewed
Source: Cairo Pharmaceuticals
The Audit Committee Report (5,153 KB)